Podcast thumbnail for Practice Point CME - Hematology Podcast

Practice Point CME - Hematology Podcast

Claim This Podcast

by Practice Point Communications

5.0(3 reviews)
51 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸
10

Podcast Authority

Beta
PoorBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality19
Social0
YouTube0
Engagement0

Podcast Overview

<p>Tune in to our hematology podcasts, where experts in the field of blood diseases unravel the complexities of hematology. Each episode covers the latest breakthroughs in the diagnosis, treatment, and management of hematologic conditions like leukemia, hemophilia, multiple myeloma and more. With in-depth discussions from leading hematologists, and insights from real-world cases, this podcast series provides healthcare professionals with the knowledge needed to navigate the world of blood disorders. Stay informed about cutting-edge research and hear inspiring stories of innovation in hematologic care.</p>

Language

🇺🇲

Publishing Since

1/20/2025

Unlock The Full Podcast Authority Score Report

See how your podcast performs across key metrics

10

Podcast Authority

Beta
PoorBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality19
Social0
YouTube0
Engagement0
4
Excellent Areas
1
Good Performance
14
Growth Opportunities
excellent
Publishing Consistency
Every 4 days
Performing excellently!
good
Website Presence
1 link(s)

Recommendations available

Unlock the full report to see detailed tips

needs improvement
Show Notes Quality
2.0/5

Recommendations available

Unlock the full report to see detailed tips

+16 More Metrics

Unlock comprehensive insights including:

  • • YouTube presence analysis
  • • Social media reach metrics
  • • RSS compliance scoring
  • • Podcast 2.0 features
  • • Technical standards
What's Included in Your Full Report

Detailed Analytics

  • Complete breakdown of all 19 authority metrics
  • Personalized recommendations for each metric
  • Industry benchmarks and comparisons
  • Technical RSS feed analysis and compliance scoring

Growth Strategies

  • Step-by-step action plans for improvement
  • Quick wins to boost your score immediately
  • Pro tips from successful podcasters
Get your free podcast insights report

See how your show performs across every key metric

Instant delivery
No spam
Attract Better Guests

High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.

Secure Sponsorships

Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.

Grow Your Audience

Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.

Reach the team behind Practice Point CME - Hematology Podcast

Verified contact details for this show aren't on file yet — sign up to get notified when they land.

Recent Episodes

Episode thumbnail for Episode 51 - Podcast: What I'd Do Differently Tomorrow - Part 5 of RRMM Podcasts: Practical Insights for the First Relapse

July 2, 2026

Episode 51 - Podcast: What I'd Do Differently Tomorrow - Part 5 of RRMM Podcasts: Practical Insights for the First Relapse

<p>Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand and clinical guidance evolves, healthcare professionals must navigate challenges related to risk stratification, treatment selection, sequencing strategies, and the integration of emerging immunotherapies into practice.</p><p>Clinicians may also face uncertainty in distinguishing mechanisms of action, managing immune-related toxicities, and selecting appropriate therapies in the context of treatment resistance. Additionally, real-world barriers such as staffing shortages, infusion capacity constraints, and workflow demands can complicate the implementation of optimal care. This podcast series features expert-led conversations that deliver practical insights and real-world strategies to support confident, guideline-informed decision-making in the management of RRMM.</p><p></p><p>Launch Date/Release: July 2, 2026</p><p>Expiration Date: August 31, 2027</p><p></p><p>FACULTY</p><p>Ajai Chari, MD</p><p>Professor of Clinical Medicine</p><p>University of California, San Francisco</p><p></p><p>Sagar Lonial, MD, FACP, FASCO</p><p>Chair and Professor</p><p>Department of Hematology and Medical Oncology</p><p>Anne and Bernard Gray Family Chair in Cancer</p><p>Chief Medical Officer</p><p>Winship Caner Institute | Emory University</p><p></p><p>This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.practicepointcme.com/CMEHome/rrmm-podcasts-practical-insights-for-the-first-relapse">this link</a> prior to listening to this podcast.</p>

Episode thumbnail for Episode 50 - Podcast: From Knowing to Doing: Overcoming Real-World Barriers - Part 4 of RRMM Podcasts: Practical Insights for the First Relapse

July 2, 2026

Episode 50 - Podcast: From Knowing to Doing: Overcoming Real-World Barriers - Part 4 of RRMM Podcasts: Practical Insights for the First Relapse

<p>Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand and clinical guidance evolves, healthcare professionals must navigate challenges related to risk stratification, treatment selection, sequencing strategies, and the integration of emerging immunotherapies into practice.</p><p>Clinicians may also face uncertainty in distinguishing mechanisms of action, managing immune-related toxicities, and selecting appropriate therapies in the context of treatment resistance. Additionally, real-world barriers such as staffing shortages, infusion capacity constraints, and workflow demands can complicate the implementation of optimal care. This podcast series features expert-led conversations that deliver practical insights and real-world strategies to support confident, guideline-informed decision-making in the management of RRMM.</p><p></p><p>Launch Date/Release: July 2, 2026</p><p>Expiration Date: August 31, 2027</p><p></p><p>FACULTY</p><p>Ajai Chari, MD</p><p>Professor of Clinical Medicine</p><p>University of California, San Francisco</p><p></p><p>Sagar Lonial, MD, FACP, FASCO</p><p>Chair and Professor</p><p>Department of Hematology and Medical Oncology</p><p>Anne and Bernard Gray Family Chair in Cancer</p><p>Chief Medical Officer</p><p>Winship Caner Institute | Emory University</p><p></p><p>This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.practicepointcme.com/CMEHome/rrmm-podcasts-practical-insights-for-the-first-relapse">this link</a> prior to listening to this podcast.</p>

Episode thumbnail for Episode 49 - Podcast: Bispecific Antibodies Across Targets: Practical Integration in RRMM - Part 3 of RRMM Podcasts: Practical Insights for the First Relapse

July 2, 2026

Episode 49 - Podcast: Bispecific Antibodies Across Targets: Practical Integration in RRMM - Part 3 of RRMM Podcasts: Practical Insights for the First Relapse

<p>Managing relapsed/refractory multiple myeloma (RRMM), particularly at first relapse, requires timely, evidence-based decisions in an increasingly complex treatment landscape. As therapeutic options continue to expand and clinical guidance evolves, healthcare professionals must navigate challenges related to risk stratification, treatment selection, sequencing strategies, and the integration of emerging immunotherapies into practice.</p><p>Clinicians may also face uncertainty in distinguishing mechanisms of action, managing immune-related toxicities, and selecting appropriate therapies in the context of treatment resistance. Additionally, real-world barriers such as staffing shortages, infusion capacity constraints, and workflow demands can complicate the implementation of optimal care. This podcast series features expert-led conversations that deliver practical insights and real-world strategies to support confident, guideline-informed decision-making in the management of RRMM.</p><p></p><p>Launch Date/Release: July 2, 2026</p><p>Expiration Date: August 31, 2027</p><p></p><p>FACULTY</p><p>Ajai Chari, MD</p><p>Professor of Clinical Medicine</p><p>University of California, San Francisco</p><p></p><p>Sagar Lonial, MD, FACP, FASCO</p><p>Chair and Professor</p><p>Department of Hematology and Medical Oncology</p><p>Anne and Bernard Gray Family Chair in Cancer</p><p>Chief Medical Officer</p><p>Winship Caner Institute | Emory University</p><p></p><p>This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.practicepointcme.com/CMEHome/rrmm-podcasts-practical-insights-for-the-first-relapse">this link</a> prior to listening to this podcast.</p>

51 total episodes available

Recent guests on Practice Point CME - Hematology Podcast

Guests from recent episodes — sign up to see every guest that has ever appeared on this show.

Dr Cindy Neunert

Guest

Deep-dive analytics for Practice Point CME - Hematology Podcast

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Practice Point CME - Hematology Podcast?
<p>Tune in to our hematology podcasts, where experts in the field of blood diseases unravel the complexities of hematology. Each episode covers the latest breakthroughs in the diagnosis, treatment, and management of hematologic conditions like leukemia, hemophilia, multiple myeloma and more. With in-depth discussions from leading hematologists, and insights from real-world cases, this podcast series provides healthcare professionals with the knowledge needed to navigate the world of blood disorders. Stay informed about cutting-edge research and hear inspiring stories of innovation in hematologic care.</p>
How often does this podcast release new episodes?

This podcast updates daily.

Where can I listen to this podcast?

This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Information about guest appearances is not available.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.